The aim of this randomized clinical trial is to compare the six months clinical performance of the self-adhesive bulk-fill composite with the conventional nano-hybrid composite in the cervical lesions of teeth in the esthetic zone. In addition, to evaluate patient's satisfaction towards the self-adhesive bulk-fill material and its total operatory time.
Cervical lesions.
Cervical lesions of at least one mm depth; to include enamel and dentin.
Cervical lesions of not more than 3 mm in depth.
Male or female genders.
Teeth showing signs of pulpitis or periapical pathosis.
Patients older than 60 years.
Patients younger than 18 years old.
Pregnant women.
Parallel
Self-Adhesive Bulkfill Composite (Surefil One)
Combination productIt is a new self-adhesive bulkfill composite that requires no previous adhesive steps.
Clinical efficacy of the self-adhesive bulkfil composite in comparison to conventional composite
Modified USPHS Criteria Alpha(A) Bravo(B) Charlie(C)
Patient's Satisfaction of the final restorations
Visual Analogue Scale (VAS). A scale 0-10; 0 - Extremely unsatisfactory 5 - Neutral 10 - Extremely satisfactory
Click on the lead sponsor to view all of their trials.
